Meeting
2015 Gastrointestinal Cancers Symposium
Preoperative infusional 5-FU and sorafenib with external radiation therapy in locally advanced rectal cancer: Results of a phase I study.
Authors
Gopi Kesaria Prithviraj
Moffitt Cancer Center, Tampa, FL
Gopi Kesaria Prithviraj , Kun Jiang , Xiuhua Zhao , Dung-Tsa Chen , Tiffany Campos , Ravi Shridhar , Sarah E. Hoffe , Khaldoun Almhanna , David Shibata , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT01376453
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 683)
DOI
10.1200/jco.2015.33.3_suppl.683
Abstract #
683
Poster Bd #
D25
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Phase I study of preoperative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Gopi Kesaria Prithviraj
Poster
2013 Gastrointestinal Cancers Symposium
A novel preoperative protocol for locally advanced rectal cancer: Hyperfractionated short-course radiotherapy combined with chemotherapy.
First Author: Hiroshi Doi
Poster
2012 ASCO Annual Meeting
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08).
First Author: Roger Von Moos
Poster
2017 Gastrointestinal Cancers Symposium
Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC).
First Author: Christina Sing-Ying Wu